Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus
Authors
Keywords
Type 2 diabetes mellitus, Cognition, Dipeptidyl peptidase-IV inhibitor, Oral glucose-lowering agent, Dementia
Journal
BMC Neurology
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-15
DOI
10.1186/s12883-018-1014-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Plasma DPP4 Activity With Mild Cognitive Impairment in Elderly Patients With Type 2 Diabetes: Results From the GDMD Study in China
- (2016) Tianpeng Zheng et al. DIABETES CARE
- Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)
- (2015) Nikolaus Marx et al. Diabetes & Vascular Disease Research
- Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes
- (2015) Insa Feinkohl et al. DIABETOLOGIA
- Cognitive function in patients with diabetes mellitus: guidance for daily care
- (2015) Paula S Koekkoek et al. LANCET NEUROLOGY
- Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus
- (2015) Onno N Groeneveld et al. Journal of Diabetes Investigation
- The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors
- (2015) Insa Feinkohl et al. Alzheimers Research & Therapy
- Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review
- (2015) Stefan L C Geijselaers et al. Lancet Diabetes & Endocrinology
- Intensive glycaemic control and cognitive decline in patients with type 2 diabetes: a meta-analysis
- (2015) R. H. Tuligenga Endocrine Connections
- Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial
- (2014) Tali Cukierman-Yaffe et al. Lancet Diabetes & Endocrinology
- Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies
- (2013) Kapil Gudala et al. Journal of Diabetes Investigation
- Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study
- (2013) Lieza G Exalto et al. Lancet Diabetes & Endocrinology
- Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
- (2013) Geert Jan Biessels et al. Lancet Diabetes & Endocrinology
- Update on incretin hormones
- (2012) Liza K. Phillips et al. Annals of the New York Academy of Sciences
- A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
- (2012) Noriko Satoh-Asahara et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4
- (2011) Song Chen et al. AGE
- Improved diabetes control in the elderly delays global cognitive decline
- (2011) José A. Luchsinger et al. Journal of Nutrition Health & Aging
- Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes — The ADDITION-Netherlands study: A cluster-randomized trial
- (2011) Paula S. Koekkoek et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy
- (2011) Lenore J Launer et al. LANCET NEUROLOGY
- Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionna
- (2011) Karen L. Smarr et al. ARTHRITIS CARE & RESEARCH
- The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans
- (2010) S. Blech et al. DRUG METABOLISM AND DISPOSITION
- Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice
- (2010) David W. Porter et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus
- (2009) E. van den Berg et al. DIABETOLOGIA
- Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
- (2009) Carolyn F Deacon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now